Want to work with healthcare technology innovators and collaborate with academic institutions in the southeast to improve patient care, support diversity and inclusion efforts, and drive differentiation and growth for your organization - download the pdf below to learn more and contact usto schedule a call.
Take a look at our library of webinars or participate in our upcoming webinars. Mark your calendar now!
XLerat-ing IDeAS - SBIR/STTR Conference
"XLerat-ing IDeAS" XLerator Network partnered with NIH, West Virginia University, Marshall University, and TechConnectWV to host a 2-day SBIR/STTR Conference to cover questions, tips, and advice on applying for NIH and NSF Funding.
The basics of drug development are well known in many labs – but what happens when you have to shift from that general understanding to developing specific plans for your own project? What’s most important to think about? Where do you find information? When do you engage with FDA or a regulatory professional? During this talk you will learn how to find information to inform your specific development effort, and how to recognize when its time to call in the professionals.
Many types of medical devices, diagnostics, and digital health products must be reviewed by the FDA Center for Devices & Radiological Health (CDRH) before they hit the market. It can be daunting for innovators to determine which regulatory approach is applicable to their technology, and how to plan ahead for their interactions with FDA. In this webinar, an overview of the most common pre-market pathways will be provided, along with several key concepts. Attendees will gain a better understanding of where to start and where to find CDRH regulatory resources relevant for their own commercialization strategy.
IP STRATEGIES: CLAIMING NEW METHODS OF USE AND NEW FORMULATIONS, AND LICENSING IP
Introduction to regulatory considerations for 505b2 application
Intellectual Property (IP) considerations for drug repurposing
Two mini case studies: new drug formulations vs new use
Presented by Gaby L. Longsworth, Ph.D., director, Sterne Kessler's Biotechnolgy & Chemical Practice Group, co-chair, Diversity Committee at Sterne Kessler, and LMG Life Sciences "Life Sciences Star", 2016-present.
COMMERCIALIZING ACADEMIC REPURPOSING DISCOVERIES: THE TECH TRANSFER AND COMPANY PERSPECTIVES
Working with the inventor/PI
Patenting and other exclusivity issues
Collaboration and negotiations
Due diligence issues
Contracting, goals and reporting
Confidentiality and other disclosures issues
Presented by Raja Krishnan, commercialization manager, University of Kentucky Office of Technology Commercialization, and Bruce Bloom, chief innovation officer, Healx. Raja Krishnan will provide an introduction and conclusion.
Moderator-led discussion with industry and regulatory experts on drug repurposing
Opportunity for audience to ask the experts questions
Panelists: Kristen Gullo, vice president of Development and Regulatory Affairs, US World Meds, Bruce Bloom, chief innovation officer, Healx, Douglas Balogh, director of Life Sciences, Guidehouse and TBD.
Moderator: Raja Krishnan, commercialization manager, University of Kentucky Office of Technology Commercialization.
Tech Transfer 101 is a 3-part webinar series for university administrators with a small or unestablished Technology Transfer Office (TTO) in the Southeast IDeA-Region (AR, KY, LA, MS, PR, SC, WV).The series addresses best practices for accelerating tech transfer and commercialization without a fully resourced office.
Session #1:Bare minimum services and recommended initiatives for building a successful Tech Transfer Program
EnRICH is a human health-focused innovation harvesting and commercialization “pre-accelerator” program for faculty and student innovators at Historically Black Colleges and Universities (HBCUs). We conducted two Q7A sessions to answer your questions. You can find the recordings of these sessions here.
Idea to Impact: The Translation and Commercialization of Academic Research
Join Fast Forward Medical Innovation for a series of live, á la carte WEBINARS intended to educate and connect life science researchers and academic innovators interested in the commercialization of academic research. The series will outline the significance and critical milestones of developing novel therapeutics, medical devices, diagnostics, and digital health innovations, as well as essential collaborations with industry partners to translate a research-based idea into a product of impact.
Translational Training for Life Science Innovators
The Translational Training Series for Life Science Innovators was developed to help train innovators regarding the unique commercialization aspects in the healthcare industry. For the first time, these videos are being delivered virtually!
There is a libraryof videos to help you as you consider strategies to translate technologies out of your lab and into the marketplace.